BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03635567-completion@plaintrial.com
DTSTAMP:20261029T034623Z
DTSTART;VALUE=DATE:20240604
SUMMARY:Efficacy and Safety Study of First-line Treatment With Pembrolizuma
 b (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women Wi
 th Persistent\, Recurrent\, or Metastatic Cervical Cancer (MK-3475-826/KEY
 NOTE-826) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03635567
URL:https://plaintrial.com/trial/NCT03635567
END:VEVENT
END:VCALENDAR
